147
Participants
Start Date
March 29, 2022
Primary Completion Date
November 4, 2028
Study Completion Date
November 4, 2028
Inclacumab
Inclacumab will be supplied in single use 10 mL vials at a concentration of 50 mg/mL. One vial contains 500 mg of inclacumab. This is a liquid concentrate for IV infusion.
Sultan Qaboos University Hospital, Muscat
Jacobi Medical Center, The Bronx
Duke University Medical Center, Durham
DUMC Investigational Drug Services Pharmacy, Durham
International Cancer Institute, Eldoret
Strada Patient Care Center, Pediatric Hematology, Mobile
University of South Alabama Children's and Women's Hospital, Mobile
KEMRI/CRDR Siaya Clinical Research Annex, Kisumu
University of Michigan Hospitals - Michigan Medicine, Ann Arbor
University of Illinois at Chicago (UIC) Clinical Research Center, Chicago
University of Illinois Hospital and Health Sciences System (UI Health), Chicago
Arkansas Children's Hospital, Little Rock
McGovern Medical School at UTHealth, Houston
UT Health Science Center at Houston - Clinical Research Unit at Memorial Hermann Hospital, Houston
UT Physicians Comprehensive Sickle Cell Center Houston, Houston
Prince Mohammed bin Nasser Hospital, Jizan
UC Irvine Medical Center, Orange
Department of Pediatrics, College of Medicine, Lagos University Teaching Hospital, Lagos
Sociedad de Oncología y hematología del Cesar, Valledupar
University of Nigeria Teaching Hospital, Enugu
University of Calabar Teaching Hospital, Calabar
Aminu Kano Teaching Hospital, Kano
Barau Dikko Teaching Hospital/Kaduna State University, Kaduna
Ahmadu Bello University Teaching Hospital, Zaria
National Hospital Abuja, Abuja
University of Abuja Teaching Hospital, Gwagwalada
UConn-Neag Comprehensive Cancer Center, Farmington
Brigham And Woman's Hospital, Boston
Dana-Farber Cancer Institute IDS Pharmacy, Boston
Dana-Farber Cancer Institute, Boston
Instituto D'Or de Pesquisa e Ensino - Hospital São Rafael, Salvador
Multihemo Servicos Medicos S/A, Recife
Hospital de Clínicas de Porto Alegre, Porto Alegre
Hospital Das Clinicas da Faculdade de Medicina de Ribeirão Preto - USP, Ribeirão Preto
Fundação Faculdade Regional de Medicina de São José do Rio Preto, São José do Rio Preto
Instituto Estadual de Hematologia Arthur Siqueira Cavalcanti - HEMORIO, Rio de Janeiro
Hospital Samaritano Higienópolis/Esho Empresa De Servicos Hospitalares S.A, São Paulo
Casa de Saude Santa Marcelina, São Paulo
CEPEC-Centro de Pesquisa Clinica, São Paulo
Clinica de la Costa Ltda., Barranquilla
Gertrude's Children's Hospital, Nairobi
Kenya Medical Research Institute - Centre for Respiratory Disease Research, Nairobi
Strathmore University CREATES, Nairobi
American University of Beirut Medical Center, Hamra
Nini Hospital, Tripoli
NIMR-Mbeya Medical Research Center, Mbeya
Acibadem Adana Hastanesi Cocuk Hematoloji Onkoloji, Adana
Baskent University Adana Appl. and Research Central, Yuregir Baskent Hospital Hematology, Adana
Hacettepe University Ihsan Dogramaci Children Hospital, Ankara
Lead Sponsor
Pfizer
INDUSTRY